BioSpace News Archive

Biotech Beach

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Daré Bioscience, Inc. announced it has entered into a royalty-backed financing agreement that provides Daré with $5 million at closing and up to an additional $7 million through three tranches over time at Daré’s option.

December 26, 2023
·
9 min read
FDA

CVRx receives FDA approval for expanded labeling of BarostimU.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF data

CVRx, Inc. announced that the U.S. Food and Drug Administration has approved revised Instructions For Use for Barostim incorporating key long-term clinical data from the BeAT-HF randomized clinical trial.

December 26, 2023
·
4 min read
Biotech Bay

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

Atreca, Inc. announced that it entered into a definitive asset purchase agreement with Immunome, Inc. to sell a collection of antibody-related assets and materials.

December 26, 2023
·
7 min read
Policy

Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm

Sofwave Medical Ltd announced clearance by the U.S. Food and Drug Administration for the Company’s 510 premarket notification submission for the improvement of the appearance of skin laxity on the upper arms and paves the way for Sofwave™ to further expand into additional treatment indications.

December 26, 2023
·
3 min read
Deals

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

Immunome, Inc. announced that it entered into a definitive asset purchase agreement with Atreca, Inc. to acquire a collection of antibody-related assets and materials.

December 26, 2023
·
4 min read
Drug Development

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

Ainos, Inc. announced that it is initiating the second phase of co-development of a volatile organic compound sensing platform, powered by AI Nose technology, in collaboration with Nisshinbo Micro Devices Inc. and Taiwan Inabata Sangyo Co.

December 26, 2023
·
8 min read
Biotech Bay

RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its IRB to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

RetinalGeniX™ Technologies Inc., announced that it has contracted with MEDsan, Inc. to conduct a study to personalize medical evaluations for patients receiving treatment for wet macular degeneration, which was previously announced on October 30, 2023.

December 26, 2023
·
5 min read
Deals

SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure

SomaLogic, Inc., a leader in proteomics technology, issued the following statement in response to a press release issued by Madryn Asset Management, LP on December 26, 2023, regarding the pending merger with Standard BioTools.

December 26, 2023
·
17 min read
Policy

Everest Medicines Announces New Drug Application Acceptance of Nefecon® in Taiwan for the Treatment of Primary IgA Nephropathy in Adult Patients

Everest Medicines announced that its New Drug Application for Nefecon® has been accepted for review by the Taiwan Food and Drug Administration for the treatment of primary immunoglobulin A nephropathy in adult patients.

December 26, 2023
·
5 min read